The Promise of a B-cell Biologic Therapy for Rheumatoid Arthritis

Armen Hareyan's picture

Treatment of rheumatoid arthritis

Drugs aimed at suppressing inflammation-provoking cytokines - specifically those linked to T-cells - have improved the treatment of rheumatoid arthritis (RA), a chronic, inflammatory autoimmune disease. Still, the frequency of remission achieved by these biologic agents remains below 50 percent. To increase the success rate of biologic therapy for

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.